Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
07/2009
07/22/2009CN101490047A Crystalline nemorubicin hydrochloride
07/22/2009CN101490046A Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
07/22/2009CN101486682A N3 alkylated benzimidazole derivatives as MEK inhibitors
07/22/2009CN100516065C 1,3,4-oxadiazol-2-ones as PPAR-delta modulators
07/22/2009CN100516063C Production method of nifuratel
07/22/2009CN100516062C New medicine
07/22/2009CN100516030C Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation
07/22/2009CN100515419C Substituted benzazoles and its application as inhibitors of Raf kinase
07/21/2009US7563908 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
07/21/2009US7563904 (S)-4-{4-[N'-(2-Oxotetrahydropyran-3-iliden)hidrazino]benzyl}-1,3-oxazolidin-2-one; industrial scale production, purity, free of using toxic reagent
07/21/2009US7563895 Quinoxaline compounds
07/21/2009US7563891 Long wavelength thiol-reactive fluorophores
07/21/2009US7563877 Macrolide antibiotics; active against Macrolides-Lincosamides-type B Streptogramines; reduction, chlorination,
07/21/2009US7563811 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
07/21/2009US7563807 Removal of aldehyde impurity by reactive polystyrene resini
07/21/2009US7563794 Ziprasidone free from colored impurities and a process for its preparation
07/21/2009US7563791 6-(Methoxymethyl)-5-(4-nitrophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine; antiproliferative agents; angiogenesis inhibition; anticarcinogenic agents; breast cancer; colon cancer; antitumor agents
07/21/2009US7563788 3-[2-(3-Ethyl-ureido)-7-pyridin-3-yl-imidazo[1,2-a]pyridin-5-yl]-[1,2,4]oxadiazole-5-carboxylic acid methylamide; antibiotic resistance; grampositive, gramnegative, anaerobic bacteria; otitis; sinusitis, pharyngitis/tonsilitis, bronchitis, urinary tract infections, skin infections, pneumonia, septicemia
07/21/2009US7563787 Substituted pyrazole compounds
07/21/2009US7563786 Substituted thiophenecarboxamides, their preparation and their use as medicaments
07/21/2009US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation
07/21/2009US7563749 cyclic dioxazine substituted pyridyl sulfonylurea derivatives and a plant safener such as dymron, fenclorim, mefenpyr-diethyl, cloquintocet-mexyl etc. for the selective control of unwanted vegetation in leguminous plants
07/21/2009CA2495943C Indoles having anti-diabetic activity
07/21/2009CA2353569C 3-(heterocyclyl)-substituted benzoylpyrazoles
07/16/2009WO2009089042A1 Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith
07/16/2009WO2009088729A1 Process for preparing n-substituted hydroxypyrimidinone carboxamides
07/16/2009WO2009087127A1 Modulators for amyloid beta
07/16/2009WO2009086835A1 Novel cyanoguanidines
07/16/2009WO2008138938A3 Process for the production of palladium supported catalysts for catalyzing heck, suzuki-miyaura sonogashira coupling and buchwald-hartwig reactions
07/16/2009US20090182144 Binding inhibitor of sphingosine-1-phosphate
07/16/2009US20090182143 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
07/16/2009US20090182142 Aromatic Compound
07/16/2009US20090182140 Alicyclic Heterocyclic Compound
07/16/2009US20090182021 Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
07/16/2009US20090181994 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/16/2009US20090181993 Hiv inhibiting 5-heterocyclyl pyrimidines
07/16/2009US20090181979 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
07/16/2009US20090181968 Novel 3-Bicyclocarbonylaminopyridine-2-Carboxamides or 3-Bicyclocarbonylaminopyrazine-2-Carboxamides
07/16/2009US20090181967 New compounds I
07/16/2009US20090181966 PGD2 receptor antagonists for the treatment of inflammatory diseases
07/16/2009US20090181965 Modulators for amyloid beta
07/16/2009US20090181964 Propane-1,3-Dione Derivative or Salt Thereof
07/16/2009US20090181963 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
07/16/2009US20090181962 Substituted thiophene compounds
07/16/2009US20090181960 17BetaHSD TYPE 5 INHIBITOR
07/16/2009US20090181958 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
07/16/2009US20090181957 Benzimidazolone derivatives as cb2 receptor ligands
07/16/2009US20090181956 Hydrazide Compound and Pesticidal Use of the Same
07/16/2009US20090181949 1h-imidazole derivative having cb1, agonistic, cb1 partial agonistic or cb1 antagnistic activity
07/16/2009US20090181948 Diamine derivative
07/16/2009US20090179552 Light emitting devices and compositions
07/16/2009CA2711803A1 Pyridine derivatives
07/16/2009CA2710987A1 Process for preparing n-substituted hydroxypyrimidinone carboxamides
07/16/2009CA2703824A1 Modulators for amyloid beta
07/15/2009EP2078717A1 6-Pyrimidinyl-pyrimid-2-one derivative
07/15/2009EP2077998A1 Phthalazine, aza- and diaza-phthalazine compounds and methods of use
07/15/2009EP2077997A1 Pyridazine derivatives
07/15/2009EP2077846A2 Benzoxazepine compounds, their preparation and use
07/15/2009EP1633771B1 Macrolide-conjugates with anti-inflammatory activity
07/15/2009EP1426365B1 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
07/15/2009CN101484451A Polymorphs of (R) -5- (2-aminoethyl) -1- (6, 8-difluorochroman-3-yl) -1,3- dihydroimidazole-thione hydrochloride
07/15/2009CN100513387C Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof
07/14/2009US7560569 (2S,4S)-1-[[(4-carbamoylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile, for treating type II diabetes; increase glucagon-like peptide activity
07/14/2009US7560565 Method for preparing derivatives of 3-hydroxypicolinic acid
07/14/2009US7560563 Process for producing 2-substituted pyridine derivative
07/14/2009US7560551 Aurora kinase modulators and method of use
07/14/2009US7560549 Sulfonyloxy derivatives
07/14/2009US7560548 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis
07/14/2009US7560547 chemical synthesis of N-[2,4-dibromo-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide; used as drugs and chemical intermediates
07/14/2009US7560546 Tyrosine kinase inhibitors
07/14/2009US7560481 Indoles are cannabinoid receptor ligands
07/14/2009US7560475 3-(2-{5-methyl-2-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-4-yl}ethoxy)phenyl]acetic acid,peroxime proliferator-activated receptor antagonists; side effect reduction; very low toxicity, especially hepatotoxicity; metabolic disorders; antidiabetic agents; anticholesterol agents; antilipemic agents
07/14/2009US7560467 Indazolo-tetrahydropyrimidine-carboxamide derivative kinase inhibitors
07/14/2009US7560466 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis
07/14/2009US7560463 Diaryl ethers as opioid receptor antagonists
07/14/2009US7560462 Compounds useful for inhibiting CHK1
07/14/2009US7560461 Quinazoline derivatives as kinase inhibitors
07/14/2009US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR)
07/14/2009US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
07/14/2009US7560456 Pesticidal pyridinecarboxamide derivatives
07/14/2009US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders
07/09/2009WO2009086041A1 Herbicidal pyridazinone derivatives
07/09/2009WO2009085945A1 Benzothiazole and benzoxazole derivatives and methods of use
07/09/2009WO2009084970A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
07/09/2009WO2009084695A1 2-aminoquinazoline derivative
07/09/2009WO2009084614A1 Imidazole carbonyl compound
07/09/2009WO2009083526A1 Novel compounds
07/09/2009WO2009056617A3 4,4-disubstituted piperdines as renin inhibitors
07/09/2009WO2009034029A3 1-substituted 4-heterocyclylpiperidines for use as cgrp antagonists
07/09/2009WO2008154642A3 Antibacterial agents
07/09/2009WO2008130368A3 Transcription factor modulating compounds and methods of use thereof
07/09/2009WO2008109180A3 Metalloprotease inhibitors containing a heterocyclic moiety
07/09/2009US20090176981 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds And Their Uses
07/09/2009US20090176980 4-[4-Isopropoxy-5-(5-isopropyl-2-methyl-phenoxymethyl)-6-methyl-pyridin-2-yl]-5-isopropyl-1H-indazole; binding antagonist and arylpyridine for antiinflammatory agents, cardiovascular disorders and antagonist or agonist and for immunology
07/09/2009US20090176859 Cathepsin cysteine protease inhibitors
07/09/2009US20090176842 Substituted arylsulfonamides as antiviral agents
07/09/2009US20090176840 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
07/09/2009US20090176823 Secondary Amines as Renin Inhibitors
07/09/2009US20090176812 3 -(4-Isopropoxyphenyl)-2-methyl-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-6-propylpyrimidin-4(3H) -one; for cardiovascular diseases, metabolic diseases and/or central nervous system diseases
07/09/2009US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer